ArticlemBio2024
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
Irene A Abela et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticlemBio2024
Irene A Abela et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.